Michael C Yang, MD
Diagnostic Radiology · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Offices
- 8
Offices
8 locations · Stanford Health Care · Smi Imaging LLC · Health Diagnostics of California A Professional Corporation
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Yang’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A124080 · Current
Licensed to practise in California · since 2012 · expires 2028-08-31 · Northwestern University Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$119,900
Medicare paid this office $119,900 for 1,374 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Nuclear medicine study from skull base to mid-thigh with ct scan | 488 | $62,856 | $121 |
| Ct scan of chest without contrast | 174 | $7,224 | $41 |
| Ct scan of abdomen and pelvis without contrast | 91 | $6,200 | $68 |
| Ct scan of abdomen and pelvis with contrast | 68 | $5,132 | $73 |
| Ct scan of abdomen and pelvis before and after contrast | 49 | $4,391 | $88 |
See all 21 services
| Nuclear medicine study from skull base to mid-thigh with ct scan | 488 | $62,856 | $121 |
| Ct scan of chest without contrast | 174 | $7,224 | $41 |
| Ct scan of abdomen and pelvis without contrast | 91 | $6,200 | $68 |
| Ct scan of abdomen and pelvis with contrast | 68 | $5,132 | $73 |
| Ct scan of abdomen and pelvis before and after contrast | 49 | $4,391 | $88 |
| Complete ultrasound scan behind abdominal cavity | 89 | $2,596 | $29 |
| Nuclear medicine study whole body with ct scan | 26 | $2,483 | $92 |
| Ct scan of chest with contrast | 41 | $1,970 | $48 |
| Low dose ct scan of chest for lung cancer screening | 29 | $1,690 | $58 |
| Complete ultrasound scan of abdomen | 50 | $1,480 | $30 |
| Mri scan of abdomen before and after contrast | 18 | $1,409 | $74 |
| Ultrasound scan of head and neck soft tissue | 63 | $1,282 | $20 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 28 | $925 | $33 |
| Ct scan of chest before and after contrast | 13 | $716 | $55 |
| Ct scan of abdomen before and after contrast | 12 | $623 | $52 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 26 | $540 | $21 |
| Limited ultrasound scan of joint or other extremity structure except blood vessels | 16 | $447 | $26 |
| Complete ultrasound scan of pelvis | 14 | $442 | $32 |
| Limited ultrasound scan of abdomen | 18 | $360 | $20 |
| Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | 12 | $338 | $28 |
| X-ray of chest, 2 views | 26 | $238 | $9 |
Who their Medicare patients are
1,374 Original Medicare patients in 2024. Average age 75 · Under 65 3% · 85 and older 10% · Women 52% · Also on Medicaid 10% · Health risk score 1.39. At or below the middle of the specialty; the typical diagnostic radiology clinician is at 1.7.
Conditions among them: High blood pressure 75% · Coronary heart disease 33% · Cancer 33% · Diabetes 32% · Chronic kidney disease 29% · COPD 25% · Depression 22% · Atrial fibrillation 20% · Heart failure 14% · Stroke 9% · Dementia 6%.
The office billed $1,048,935, Medicare allowed $154,773 and paid $119,900; for 2,542 services of 59 kinds; $219 of it was for drugs given in the office and $119,680 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 1,374 | 2,542 | 75 | 1.39 | $1,048,935 | $119,900 |
| 2023 | 1,695 | 25,016 | 74 | 1.67 | $1,737,201 | $562,876 |
| 2022 | 1,719 | 3,120 | 73 | 1.41 | $550,335 | $153,064 |
| 2021 | 2,034 | 7,437 | 73 | 1.46 | $757,712 | $204,087 |
| 2020 | 1,449 | 6,569 | 73 | 1.61 | $500,534 | $132,495 |
| 2019 | 1,306 | 29,361 | 73 | 1.65 | $2,006,711 | $690,583 |
| 2018 | 1,164 | 34,818 | 73 | 1.61 | $1,785,894 | $606,562 |
| 2017 | 1,143 | 35,660 | 73 | 1.77 | $2,207,019 | $560,451 |
| 2016 | 1,067 | 37,459 | 72 | 1.88 | $2,415,432 | $592,859 |
| 2015 | 998 | 27,792 | 71 | 1.91 | $2,127,776 | $546,633 |
| 2014 | 311 | 1,936 | 72 | 2.26 | $376,958 | $123,456 |
| 2013 | 31 | 32 | 73 | 2.48 | $1,924 | $276 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 30 services
| Nuclear medicine study from skull base to mid-thigh with ct scan | 379 | $278,917 | $497 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 180 | $57,564 | $286 |
| Nuclear medicine study whole body with ct scan | 60 | $32,895 | $422 |
| Ct scan of abdomen and pelvis before and after contrast | 85 | $22,869 | $172 |
| Ct scan of abdomen and pelvis with contrast | 168 | $22,373 | $108 |
| Ct scan of chest without contrast | 213 | $20,437 | $60 |
| Mri scan of abdomen before and after contrast | 52 | $14,613 | $176 |
| Ct scan of abdomen and pelvis without contrast | 99 | $12,434 | $86 |
| Complete ultrasound scan of abdomen | 137 | $11,178 | $56 |
| Ct scan of chest with contrast | 153 | $9,737 | $52 |
| Low dose ct scan of chest for lung cancer screening | 59 | $8,059 | $83 |
| Mri scan of pelvis before and after contrast | 32 | $7,294 | $152 |
| Ct scan of chest before and after contrast | 43 | $5,356 | $77 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 35 | $5,314 | $97 |
| Complete ultrasound scan of pelvis | 61 | $4,751 | $52 |
| Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | 52 | $4,545 | $56 |
| Ct scan of blood vessels of chest with contrast | 19 | $4,325 | $135 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 49 | $4,311 | $56 |
| Ultrasound of leg arteries or artery grafts | 21 | $3,879 | $129 |
| Ultrasound of both sides of head and neck blood flow | 25 | $3,526 | $98 |
| Complete ultrasound scan behind abdominal cavity | 55 | $3,274 | $44 |
| Mri scan of abdomen without contrast | 14 | $1,999 | $100 |
| Limited ultrasound scan behind abdominal cavity | 44 | $1,990 | $28 |
| Ultrasound scan of abdominal aorta | 17 | $1,708 | $71 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 162 | $1,527 | $0 |
| Ultrasound of abdomen and pelvis artery and vein blood flow | 13 | $1,148 | $72 |
| Ultrasound scan of head and neck soft tissue | 16 | $1,041 | $50 |
| Injection, gadoterate meglumine, 0.1 ml | 53 | $959 | $0 |
| Limited ultrasound scan of abdomen | 15 | $830 | $42 |
| Ultrasound scan of scrotum | 13 | $511 | $30 |
2022: 30 services
| Nuclear medicine study from skull base to mid-thigh with ct scan | 304 | $55,240 | $167 |
| Ct scan of chest without contrast | 201 | $8,728 | $42 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 28 | $8,407 | $290 |
| Mri scan of abdomen before and after contrast | 92 | $8,194 | $88 |
| Ct scan of abdomen and pelvis before and after contrast | 92 | $7,759 | $83 |
| Ct scan of abdomen and pelvis with contrast | 88 | $7,231 | $79 |
| Complete ultrasound scan of abdomen | 190 | $6,918 | $36 |
| Ct scan of abdomen and pelvis without contrast | 84 | $5,865 | $70 |
| Complete ultrasound scan of pelvis | 101 | $3,364 | $33 |
| Mri scan of pelvis before and after contrast | 40 | $3,362 | $84 |
| Low dose ct scan of chest for lung cancer screening | 29 | $3,300 | $114 |
| Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | 95 | $3,217 | $33 |
| Nuclear medicine study whole body with ct scan | 34 | $3,206 | $92 |
| Ct scan of chest with contrast | 61 | $3,006 | $47 |
| Ct scan of chest before and after contrast | 44 | $2,318 | $50 |
| Ultrasound of both sides of head and neck blood flow | 40 | $2,026 | $51 |
| Ultrasound scan of head and neck soft tissue | 71 | $1,725 | $24 |
| Mri scan of abdomen without contrast | 27 | $1,725 | $64 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 43 | $1,631 | $38 |
| Limited ultrasound scan behind abdominal cavity | 74 | $1,626 | $22 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 54 | $1,328 | $24 |
| Complete ultrasound scan behind abdominal cavity | 36 | $1,134 | $31 |
| Ultrasound of leg arteries or artery grafts | 20 | $992 | $50 |
| Limited ultrasound scan of abdomen | 38 | $929 | $24 |
| Mri scan of pelvis without contrast | 14 | $730 | $52 |
| Ct scan of abdomen before and after contrast | 12 | $705 | $59 |
| Ultrasound scan of abdominal aorta | 24 | $693 | $29 |
| Ct scan of abdomen without contrast | 15 | $662 | $44 |
| Limited ultrasound scan of joint or other extremity structure except blood vessels | 21 | $490 | $22 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 13 | $90 | $0 |
2021: 43 services
| Nuclear medicine study from skull base to mid-thigh with ct scan | 311 | $58,645 | $167 |
| Low dose ct scan of chest for lung cancer screening | 264 | $17,952 | $67 |
| Ct scan of abdomen and pelvis before and after contrast | 156 | $14,625 | $89 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 51 | $14,348 | $276 |
| Ct scan of abdomen and pelvis without contrast | 144 | $10,999 | $74 |
| Ct scan of chest without contrast | 223 | $10,941 | $45 |
| Ct scan of abdomen and pelvis with contrast | 103 | $9,077 | $81 |
| Nuclear medicine study whole body with ct scan | 23 | $5,623 | $234 |
| Screening mammography | 64 | $4,889 | $75 |
| Ct scan of chest with contrast | 83 | $4,522 | $48 |
| Mri scan of abdomen before and after contrast | 40 | $4,209 | $103 |
| Complete ultrasound scan of abdomen | 94 | $3,402 | $36 |
| Mri scan of lower spinal canal without contrast | 19 | $3,243 | $154 |
| Ct scan of chest before and after contrast | 54 | $2,965 | $53 |
| Mri scan of pelvis before and after contrast | 20 | $2,397 | $114 |
| Screening 3d breast mammography | 53 | $2,158 | $41 |
| Complete ultrasound scan of pelvis | 55 | $2,124 | $38 |
| Ultrasound scan of head and neck soft tissue | 42 | $1,678 | $40 |
| Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | 41 | $1,611 | $38 |
| Ct scan of abdomen and pelvis with contrast | 17 | $1,495 | $83 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 23 | $1,412 | $59 |
| Complete ultrasound scan behind abdominal cavity | 27 | $1,363 | $49 |
| Limited ultrasound scan behind abdominal cavity | 43 | $1,319 | $31 |
| Mri scan of abdomen without contrast | 18 | $1,103 | $55 |
| Ct scan of blood vessels of chest with contrast | 12 | $1,008 | $84 |
| Limited ultrasound scan of abdomen | 25 | $892 | $34 |
| Ct scan of chest with contrast | 16 | $860 | $51 |
| Ct scan of abdomen before and after contrast | 15 | $835 | $56 |
| Mri scan of pelvis without contrast | 11 | $808 | $73 |
| Ct scan of abdomen without contrast | 15 | $737 | $49 |
| X-ray of chest, 2 views | 70 | $731 | $9 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 32 | $663 | $20 |
| Ultrasound scan of abdominal aorta | 14 | $520 | $35 |
| Limited ultrasound scan of 1 breast | 14 | $515 | $37 |
| Ultrasound of both sides of head and neck blood flow | 11 | $494 | $45 |
| Ct scan of heart with evaluation of blood vessel calcium | 14 | $418 | $28 |
| Limited ultrasound scan of joint or other extremity structure except blood vessels | 13 | $330 | $25 |
| Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 11 | $299 | $27 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 38 | $277 | $0 |
| X-ray of lower and sacral spine, 2-3 views | 14 | $223 | $12 |
| X-ray of shoulder, minimum of 2 views | 16 | $207 | $11 |
| X-ray of lower and sacral spine, minimum of 4 views | 11 | $198 | $15 |
| X-ray of abdomen, 1 view | 11 | $114 | $8 |
2020: 26 services
| Nuclear medicine study from skull base to mid-thigh with ct scan | 275 | $39,936 | $125 |
| Ct scan of abdomen and pelvis before and after contrast | 161 | $14,357 | $87 |
| Ct scan of chest without contrast | 235 | $12,002 | $48 |
| Ct scan of abdomen and pelvis without contrast | 148 | $11,154 | $72 |
| Low dose ct scan (ldct) for lung cancer screening | 125 | $9,192 | $72 |
| Ct scan of abdomen and pelvis with contrast | 91 | $8,507 | $83 |
| Nuclear medicine study whole body with ct scan | 35 | $5,370 | $141 |
| Ct scan of chest with contrast | 81 | $4,561 | $51 |
| Ct scan of chest before and after contrast | 57 | $3,400 | $53 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 13 | $2,631 | $202 |
| Mri scan of abdomen before and after contrast | 27 | $2,614 | $93 |
| Complete ultrasound scan of abdomen | 51 | $1,705 | $33 |
| Ct scan of abdomen before and after contrast | 25 | $1,599 | $62 |
| Mri scan of pelvis before and after contrast | 17 | $1,551 | $91 |
| Ct scan of blood vessels of chest with contrast | 15 | $1,198 | $80 |
| Ct scan of abdomen without contrast | 18 | $1,025 | $57 |
| Complete ultrasound scan of pelvis | 28 | $782 | $27 |
| Complete ultrasound scan behind abdominal cavity | 16 | $640 | $40 |
| Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | 20 | $630 | $30 |
| Ct scan of heart with evaluation of blood vessel calcium | 18 | $614 | $34 |
| Ultrasound scan of head and neck soft tissue | 17 | $533 | $31 |
| Limited ultrasound scan behind abdominal cavity | 18 | $517 | $26 |
| Limited ultrasound scan of abdomen | 17 | $477 | $28 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 40 | $293 | $0 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 12 | $293 | $24 |
| X-ray of chest, 2 views | 30 | $275 | $9 |
2019: 28 services
| Nuclear medicine study from skull base to mid-thigh with ct scan | 279 | $396,451 | $1,330 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 301 | $64,151 | $199 |
| Ct scan of abdomen and pelvis before and after contrast | 145 | $45,932 | $310 |
| Nuclear medicine study whole body with ct scan | 26 | $33,963 | $1,306 |
| Ct scan of chest without contrast | 257 | $33,687 | $126 |
| Ct scan of abdomen and pelvis without contrast | 100 | $17,168 | $168 |
| Ct scan of abdomen and pelvis with contrast | 65 | $15,560 | $232 |
| Low dose ct scan (ldct) for lung cancer screening | 46 | $11,923 | $259 |
| Ct scan of chest before and after contrast | 55 | $8,657 | $152 |
| Ct scan of chest with contrast | 62 | $7,170 | $110 |
| Screening mammography | 34 | $4,968 | $146 |
| Ct scan of abdomen before and after contrast | 18 | $4,280 | $238 |
| Ct scan of blood vessels of chest with contrast | 17 | $4,191 | $247 |
| Complete ultrasound scan of abdomen | 40 | $3,877 | $97 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 267 | $2,222 | $0 |
| Complete ultrasound scan of 1 breast | 14 | $1,877 | $134 |
| Ct scan of abdomen without contrast | 15 | $1,861 | $124 |
| Ct scan of abdomen with contrast | 11 | $1,768 | $161 |
| Ct scan of abdomen and pelvis with contrast | 20 | $1,668 | $83 |
| Complete ultrasound scan of pelvis | 20 | $1,646 | $82 |
| Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | 18 | $1,629 | $86 |
| Ultrasound scan of head and neck soft tissue | 14 | $1,386 | $92 |
| Screening 3d breast mammography | 21 | $1,223 | $58 |
| Complete ultrasound scan behind abdominal cavity | 12 | $1,009 | $84 |
| X-ray of chest, 2 views | 36 | $875 | $24 |
| Ct scan of chest with contrast | 17 | $875 | $51 |
| Limited ultrasound scan behind abdominal cavity | 16 | $681 | $43 |
| Injection, gadoterate meglumine, 0.1 ml | 14 | $388 | $0 |
2018: 28 services
| Nuclear medicine study from skull base to mid-thigh with ct scan | 231 | $328,768 | $1,320 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 252 | $51,855 | $192 |
| Ct scan of abdomen and pelvis before and after contrast | 116 | $34,847 | $298 |
| Nuclear medicine study whole body with ct scan | 24 | $33,515 | $1,341 |
| Ct scan of chest without contrast | 167 | $21,858 | $129 |
| Ct scan of abdomen and pelvis without contrast | 115 | $19,187 | $165 |
| Low dose ct scan (ldct) for lung cancer screening | 57 | $14,887 | $261 |
| Ct scan of abdomen and pelvis with contrast | 57 | $13,082 | $230 |
| Mri scan of abdomen before and after contrast | 31 | $11,948 | $385 |
| Ct scan of chest before and after contrast | 52 | $8,412 | $156 |
| Ct scan of chest with contrast | 65 | $7,730 | $119 |
| Complete ultrasound scan of abdomen | 67 | $6,947 | $102 |
| Mri scan of pelvis before and after contrast | 17 | $5,412 | $301 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 23 | $4,073 | $177 |
| Mri scan of abdomen without contrast | 16 | $3,664 | $229 |
| Ct scan of abdomen before and after contrast | 16 | $3,447 | $215 |
| Ultrasound of both sides of head and neck blood flow | 19 | $3,241 | $171 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 23 | $2,529 | $110 |
| Complete ultrasound scan of pelvis | 29 | $2,417 | $83 |
| Ultrasound of leg arteries or artery grafts | 11 | $2,388 | $217 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 247 | $2,295 | $0 |
| Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | 20 | $2,108 | $105 |
| Ultrasound scan of head and neck soft tissue | 19 | $1,963 | $103 |
| Limited ultrasound scan behind abdominal cavity | 26 | $1,293 | $48 |
| Ct scan of abdomen without contrast | 12 | $1,206 | $100 |
| Injection, gadoterate meglumine, 0.1 ml | 40 | $1,176 | $0 |
| Complete ultrasound scan behind abdominal cavity | 12 | $1,135 | $95 |
| X-ray of chest, 2 views | 43 | $956 | $22 |
2017: 26 services
| Nuclear medicine study from skull base to mid-thigh with ct scan | 223 | $287,067 | $1,222 |
| Nuclear medicine study whole body with ct scan | 42 | $52,828 | $1,258 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 256 | $49,628 | $186 |
| Ct scan of abdomen and pelvis before and after contrast | 112 | $31,285 | $277 |
| Ct scan of chest without contrast | 192 | $23,237 | $115 |
| Mri scan of abdomen before and after contrast | 37 | $15,722 | $403 |
| Ct scan of abdomen and pelvis without contrast | 97 | $13,960 | $142 |
| Ct scan of abdomen and pelvis with contrast | 59 | $13,756 | $233 |
| Ct scan of chest with contrast | 68 | $9,914 | $138 |
| Ct scan of chest before and after contrast | 42 | $7,586 | $172 |
| Low dose ct scan (ldct) for lung cancer screening | 25 | $6,735 | $269 |
| Mri scan of pelvis before and after contrast | 11 | $4,202 | $350 |
| Complete ultrasound scan of abdomen | 40 | $3,745 | $94 |
| Ultrasound scan of head and neck soft tissue | 31 | $3,002 | $97 |
| Mri scan of abdomen without contrast | 15 | $2,791 | $186 |
| Ct scan of abdomen before and after contrast | 12 | $2,611 | $201 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 249 | $2,439 | $0 |
| Ct scan of abdomen without contrast | 17 | $1,807 | $106 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 16 | $1,705 | $100 |
| Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | 16 | $1,568 | $98 |
| Ct scan of abdomen and pelvis with contrast | 22 | $1,492 | $68 |
| Complete ultrasound scan of pelvis | 15 | $1,360 | $85 |
| Injection, gadoterate meglumine, 0.1 ml | 42 | $1,224 | $0 |
| Ct scan of chest with contrast | 18 | $860 | $48 |
| X-ray of chest, 2 views, front and side | 40 | $842 | $21 |
| Limited ultrasound scan behind abdominal cavity | 12 | $574 | $48 |
2016: 22 services
| Nuclear medicine study from skull base to mid-thigh with ct scan | 244 | $316,265 | $1,245 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 266 | $53,657 | $194 |
| Ct scan of abdomen and pelvis before and after contrast | 148 | $44,662 | $294 |
| Nuclear medicine study whole body with ct scan | 31 | $39,100 | $1,261 |
| Ct scan of chest without contrast | 200 | $27,212 | $131 |
| Ct scan of abdomen and pelvis without contrast | 121 | $20,130 | $157 |
| Ct scan of abdomen and pelvis with contrast | 59 | $15,997 | $258 |
| Mri scan of abdomen before and after contrast | 32 | $13,528 | $410 |
| Ct scan of chest with contrast | 79 | $12,508 | $151 |
| Ct scan of chest before and after contrast | 57 | $9,924 | $168 |
| Mri scan of abdomen without contrast | 23 | $5,556 | $242 |
| Ct scan of abdomen before and after contrast | 22 | $4,516 | $205 |
| Mri scan of pelvis before and after contrast | 13 | $3,722 | $286 |
| Ct scan of abdomen without contrast | 30 | $3,352 | $112 |
| Mri scan of pelvis without contrast | 12 | $3,333 | $256 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 315 | $3,035 | $0 |
| Ct scan of abdomen and pelvis with contrast | 21 | $1,383 | $66 |
| Complete ultrasound scan of abdomen | 12 | $1,129 | $94 |
| Injection, gadoterate meglumine, 0.1 ml | 26 | $644 | $0 |
| Ct scan of chest with contrast | 13 | $506 | $39 |
| X-ray of chest, 2 views, front and side | 19 | $410 | $22 |
| Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | 11 | $305 | $1 |
2015: 25 services
| Nuclear medicine study from skull base to mid-thigh with ct scan | 235 | $296,178 | $1,204 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 264 | $52,115 | $190 |
| Nuclear medicine study whole body with ct scan | 39 | $46,642 | $1,196 |
| Ct scan of abdomen and pelvis before and after contrast | 143 | $42,148 | $291 |
| Ct scan of chest without contrast | 131 | $19,070 | $137 |
| Ct scan of abdomen and pelvis without contrast | 96 | $15,539 | $162 |
| Mri scan of abdomen before and after contrast | 24 | $10,167 | $391 |
| Ct scan of chest before and after contrast | 54 | $9,496 | $173 |
| Ct scan of chest with contrast | 49 | $8,080 | $158 |
| Ct scan of abdomen and pelvis with contrast | 22 | $5,617 | $255 |
| Ct scan of abdomen before and after contrast | 24 | $4,993 | $200 |
| Mri scan of abdomen without contrast | 14 | $3,888 | $278 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 249 | $2,982 | $0 |
| Ultrasound of leg arteries or artery grafts | 15 | $2,557 | $170 |
| Ct scan of blood vessels of chest with contrast | 11 | $2,471 | $225 |
| Complete ultrasound scan of abdomen | 23 | $2,198 | $96 |
| Ct scan of abdomen without contrast | 13 | $1,621 | $125 |
| Ct scan of pelvis without contrast | 12 | $1,576 | $121 |
| Ct scan of abdomen and pelvis with contrast | 19 | $1,330 | $70 |
| Limited ultrasound scan behind abdominal cavity | 28 | $1,258 | $45 |
| Limited ultrasound scan of abdomen | 11 | $763 | $69 |
| Ultrasound scan of head and neck soft tissue | 11 | $756 | $69 |
| Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | 26 | $661 | $1 |
| Ct scan of chest with contrast | 17 | $658 | $39 |
| X-ray of chest, 2 views, front and side | 26 | $560 | $22 |
2014: 6 services
| Nuclear medicine study from skull base to mid-thigh with ct scan | 74 | $90,460 | $1,206 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 77 | $15,265 | $196 |
| Ct scan of abdomen and pelvis before and after contrast | 11 | $3,509 | $319 |
| X-ray of chest, 2 views, front and side | 135 | $1,121 | $8 |
| X-ray of chest, 1 view, front | 53 | $396 | $7 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 15 | $279 | $0 |
2013: 1 service
| X-ray of chest, 2 views, front and side | 22 | $196 | $9 |
Medicaid work
$113,555 in 2024
Medicaid paid $113,555 for 332 billed services this clinician did in 2024, up to 26 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh | 153 | $95,270 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 86 | $12,648 |
| Ultrasound, soft tissues of head and neck (eg, thyroid, parathyroid, parotid), real time with image documentation | 41 | $3,226 |
| Ultrasound, abdominal, real time with image documentation; complete | 13 | $1,219 |
| US RETROPERITONEAL REAL TIME W/IMAGE COMPLETE | 13 | $987 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 26 | $205 |
| 2024 | 332 | 6 | 26 | $113,555 |
| 2023 | 1,049 | 7 | 53 | $25,735 |
| 2022 | 2,383 | 14 | 92 | $40,764 |
| 2021 | 1,589 | 18 | 54 | $40,351 |
| 2020 | 1,303 | 12 | 50 | $26,055 |
| 2019 | 1,104 | 12 | 50 | $10,552 |
| 2018 | 374 | 8 | 42 | $2,399 |
See the largest Medicaid services in earlier years
2023
| Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh | 36 | $12,324 |
| Ultrasound, abdominal, real time with image documentation; complete | 250 | $4,136 |
| Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 342 | $3,097 |
| Ultrasound by transvaginal approach | 328 | $2,991 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 25 | $2,895 |
| US RETROPERITONEAL REAL TIME W/IMAGE COMPLETE | 41 | $275 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 27 | $17 |
2022
| Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh | 105 | $29,176 |
| Ultrasound, abdominal, real time with image documentation; complete | 492 | $3,486 |
| Ultrasound by transvaginal approach | 607 | $2,876 |
| Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 716 | $1,938 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 84 | $1,075 |
| Magnetic resonance (eg, proton) imaging, pelvis; without contrast material(s), followed by contrast material(s) and further sequences | 25 | $742 |
| US RETROPERITONEAL REAL TIME W/IMAGE COMPLETE | 88 | $623 |
| Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences | 26 | $400 |
| Ultrasound, soft tissues of head and neck (eg, thyroid, parathyroid, parotid), real time with image documentation | 45 | $197 |
| EXTREMITY STUDY | 46 | $183 |
| Ultrasound, retroperitoneal (eg, renal, aorta, nodes), real time with image documentation; limited | 12 | $46 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 56 | $21 |
2021
| Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh | 58 | $14,079 |
| Screening mammography, bilateral (2-view study of each breast), including computer-aided detection (CAD) when performed | 120 | $6,873 |
| Ultrasound by transvaginal approach | 333 | $3,100 |
| Magnetic resonance (eg, proton) imaging, spinal canal and contents, lumbar; without contrast material | 27 | $2,718 |
| Magnetic resonance (eg, proton) imaging, any joint of lower extremity; without contrast material | 23 | $2,520 |
| Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 398 | $2,202 |
| Computed tomography, thorax, diagnostic; without contrast material | 12 | $1,697 |
| Ultrasound, abdominal, real time with image documentation; complete | 202 | $1,525 |
| SCREENING DIGITAL BREAST TOMOSYNTHESIS BI | 45 | $1,324 |
| Computed tomography, thorax, low dose for lung cancer screening, without contrast material(s) | 72 | $1,152 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 43 | $1,080 |
| Ultrasound, breast, unilateral, real time with image documentation, including axilla when performed; limited | 34 | $776 |
2020
| Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh | 74 | $17,010 |
| Computed tomography, abdomen and pelvis; without contrast material in one or both body regions, followed by contrast material(s) and further sections in one or both body regions | 113 | $2,106 |
| Computed tomography, thorax, diagnostic; without contrast material | 102 | $1,521 |
| Low dose ct scan (ldct) for lung cancer screening | 32 | $1,385 |
| Ultrasound, abdominal, real time with image documentation; complete | 153 | $1,079 |
| CT ABDOMEN & PELVIS W/O CONTRAST MATERIAL | 57 | $860 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 61 | $716 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 345 | $677 |
| Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 202 | $327 |
| CT ABDOMEN & PELVIS W/CONTRAST MATERIAL | 12 | $312 |
| Ultrasound by transvaginal approach | 140 | $61 |
| DIAGNOSTIC COMPUTED TOMOGRAPHY THORAX W/CONTRAST | 12 | $0 |
2019
| Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh | 51 | $7,058 |
| Computed tomography, abdomen and pelvis; without contrast material in one or both body regions, followed by contrast material(s) and further sections in one or both body regions | 98 | $1,555 |
| Computed tomography, thorax, diagnostic; without contrast material | 177 | $739 |
| Ultrasound, abdominal, real time with image documentation; complete | 68 | $437 |
| CT ABDOMEN & PELVIS W/CONTRAST MATERIAL | 14 | $279 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 362 | $191 |
| Radiologic examination, chest; 2 views | 12 | $109 |
| Ultrasound by transvaginal approach | 107 | $67 |
| Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 119 | $67 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 58 | $50 |
| CT ABDOMEN & PELVIS W/O CONTRAST MATERIAL | 26 | $0 |
| Low dose ct scan (ldct) for lung cancer screening | 12 | $0 |
2018
| Computed tomography, abdomen and pelvis; without contrast material in one or both body regions, followed by contrast material(s) and further sections in one or both body regions | 18 | $663 |
| Computed tomography, thorax, diagnostic; without contrast material | 29 | $478 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 14 | $360 |
| Ultrasound, abdominal, real time with image documentation; complete | 38 | $359 |
| CT ABDOMEN & PELVIS W/CONTRAST MATERIAL | 12 | $254 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 197 | $163 |
| Ultrasound by transvaginal approach | 15 | $61 |
| Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 51 | $61 |
Money from drug and device companies
$450 in 2025
| 2025 | 2 | 5 | None | $450 |
| 2024 | 3 | 6 | None | $680 |
| 2023 | 1 | 1 | None | $18 |
| 2020 | 1 | 1 | None | $22 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Shockwave Medical | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $427 | 4 payments
|
| Apellis Pharmaceuticals | Syfovre | $23 | 1 payment
|
See all 5 published payments
| Shockwave Medical | Meals · 2025-06-22 | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $135 |
| Shockwave Medical | Meals · 2025-06-18 | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $122 |
| Shockwave Medical | Meals · 2025-06-02 | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $150 |
| Shockwave Medical | Meals · 2025-05-22 | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $19 |
| Apellis Pharmaceuticals | Meals · 2025-04-30 | Syfovre | $23 |
See earlier years (2024, 2023, 2020)
2024: $680
| ShockWave Medical | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $512 | 4 payments
|
| Boston Scientific | Watchman | $150 | 1 payment
|
| Sun Pharmaceutical Industries | Cequa | $18 | 1 payment
|
2023: $18
| Sun Pharmaceutical Industries | Cequa | $18 | 1 payment
|
2020: $22
| Eisai | Lenvima | $22 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 92.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1124261573
- Licence
- CA A124080California A124080: Current · expires 2028-08-31
- Trained
- Northwestern University Feinberg Medical School, 2008
- Group
- Stanford Health Care · Smi Imaging LLC · Health Diagnostics of California A Professional Corporation
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 2085B0100X (2085B0100X); Diagnostic radiology (2085R0202X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2009-04-15
- NPI last updated
- 2024-04-05
- NPI record certified
- 2024-04-05
This is when the NPI record was last certified, not a medical board exam.